Nancy King to Ethics Committees, Research
This is a "connection" page, showing publications Nancy King has written about Ethics Committees, Research.
Connection Strength
1.180
-
King NM. Who's Winning the IRB Wars? The Struggle for the Soul of Human Research. Perspect Biol Med. 2018; 61(3):450-464.
Score: 0.635
-
King NM, Iltis AS. Introduction: research ethics: reexamining key concerns. J Law Med Ethics. 2012; 40(4):865-6.
Score: 0.419
-
Churchill LR, Nelson DK, Henderson GE, King NM, Davis AM, Leahey E, Wilfond BS. Assessing benefits in clinical research: why diversity in benefit assessment can be risky. IRB. 2003 May-Jun; 25(3):1-8.
Score: 0.057
-
Weinfurt KP, Hall MA, King NM, Friedman JY, Schulman KA, Sugarman J. Disclosure of financial relationships to participants in clinical research. N Engl J Med. 2009 Aug 27; 361(9):916-21.
Score: 0.022
-
Kipnis K, King NM, Nelson RM. An open letter to institutional review boards considering Northfield Laboratories' PolyHeme trial. Am J Bioeth. 2006 May-Jun; 6(3):18-21.
Score: 0.018
-
Kipnis K, King NM, Nelson RM. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver. IRB. 2006 Mar-Apr; 28(2):16-9.
Score: 0.017
-
King NM. Health policy--ensuring informed consent in human experimentation: a comparison of the approaches of two states. North Carol Law Rev. 1979 Oct; 58(1):137-52.
Score: 0.011